Replimune Group Ownership | Who Owns Replimune Group?
Replimune Group Ownership Summary
Replimune Group is owned by 90.56% institutional investors, 1.99% insiders, and 7.45% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 12.07% of REPL shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 5.47% of its assets in Replimune Group shares.
REPL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Replimune Group | 90.56% | 1.99% | 7.45% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 11.05M | 12.07% | $46.28M |
| Price t rowe associates inc /md/ | 8.31M | 9.08% | $34.80M |
| Blackrock | 4.71M | 7.08% | $42.42M |
| Rtw investments, lp | 6.40M | 6.99% | $26.80M |
| Blackrock funding, inc. /de | 5.78M | 6.31% | $24.20M |
| Fcpm iii services b.v. | 4.16M | 4.54% | $17.42M |
| Point72 asset management | 3.63M | 3.97% | $15.21M |
| Vanguard group | 3.48M | 3.80% | $14.58M |
| Tang capital management | 3.40M | 3.72% | $14.25M |
| State street | 2.92M | 3.20% | $12.25M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 4.16M | 3.48% | $17.42M |
| Boxer capital management | 1.05M | 1.40% | $4.40M |
| Ghost tree capital | 450.00K | 1.27% | $4.05M |
| Sofinnova investments | 1.81M | 1.03% | $16.78M |
| Boxer capital | 1.54M | 0.73% | $13.83M |
| Tang capital management | 3.40M | 0.55% | $14.25M |
| Omega fund management | 248.67K | 0.47% | $1.04M |
| Readystate asset management lp | 2.62M | 0.47% | $10.98M |
| Nan fung group | 63.72K | 0.45% | $266.98K |
| Adar1 capital management | 978.89K | 0.39% | $4.10M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | 6.40M | 0.33% | 4.33M |
| Point72 asset management | 3.63M | 0.03% | 2.92M |
| Readystate asset management lp | 2.62M | 0.47% | 2.43M |
| Braidwell lp | 2.75M | 0.34% | 2.33M |
| Erste asset management gmbh | 1.63M | 0.07% | 1.62M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Redmile group | 535.82K | 0.22% | -4.13M |
| Price t rowe associates inc /md/ | 8.31M | 0.00% | -2.51M |
| Atlas venture life science advisors | - | - | -2.10M |
| Marshall wace, llp | - | - | -1.87M |
| Omega fund management | 248.67K | 0.47% | -1.73M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Boxer capital | 1.54M | 0.73% | 1.54M | $13.83M |
| Toronto dominion bank | 1.37M | 0.01% | 1.37M | $5.75M |
| Quinn opportunity partners | 650.72K | 0.19% | 650.72K | $2.73M |
| Norges bank | 459.90K | 0.00% | 459.90K | $4.14M |
| Jump financial | 243.77K | 0.01% | 243.77K | $1.02M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -4.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Global retirement partners | -32.00 |
| Creative financial designs inc /adv | -33.00 |
| Stephens consulting | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 187 | 3.89% | 82,873,954 | 6.75% | 90 | 1.26% | 105 | 25.00% | 48 | -20.00% |
| Jun 30, 2025 | 189 | 13.17% | 80,918,624 | 7.29% | 88 | 1.08% | 86 | -2.27% | 65 | 35.42% |
| Mar 31, 2025 | 170 | 6.25% | 81,976,905 | 5.26% | 98 | 1.13% | 88 | -11.11% | 49 | 48.48% |
| Dec 31, 2024 | 91 | -38.10% | 20,304,371 | -70.81% | 25 | 0.33% | 55 | -30.38% | 17 | -56.41% |
| Sep 30, 2024 | 147 | -2.65% | 69,570,682 | -1.86% | 88 | 0.84% | 80 | -8.05% | 39 | -17.02% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 4.21M | 5.47% | -451.47K |
| T. Rowe Price New Horizons | 4.21M | 5.39% | -7.08K |
| Vanguard US Total Market Shares ETF | 2.02M | 2.63% | 478.00K |
| T. Rowe Price Health Sciences | 1.73M | 2.22% | -165.39K |
| Vanguard Total Stock Mkt Idx Inv | 1.71M | 2.19% | -37.82K |
| T. Rowe Price Integrated US Sm Gr Eq | 1.60M | 2.05% | 117.60K |
| iShares Russell 2000 ETF | 1.58M | 2.03% | - |
| T. Rowe Price Integrated US SmCapGrEq | 1.48M | 1.92% | - |
| T. Rowe Price New Horizons Tr-A | 1.30M | 1.69% | 21.57K |
| T. Rowe Price New Horizons Tr-Z | 1.28M | 1.66% | 1.80K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 02, 2025 | Patel Sushil | Chief Executive Officer | Sell | $111.30K |
| Nov 17, 2025 | Sarchi Christopher | Chief Commercial Officer | Sell | $47.39K |
| Nov 17, 2025 | Xynos Konstantinos | Chief Medical Officer | Sell | $65.96K |
| Aug 15, 2025 | Hill Emily Luisa | Chief Financial Officer | Sell | $49.16K |
| May 20, 2025 | Astley-Sparke Philip | - | Sell | $260.17K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | 6 |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 3 |
REPL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools